December 3, 2021
MSD said on December 3 that it has filed its COVID-19 treatment molnupiravir in Japan seeking special emergency approval. It marks the first regulatory submission made in the country for an oral coronavirus treatment. Currently, Japan’s special emergency approval pathway...read more